Pain durinng ESWL. Postprocedural disorder of genitourinary system, unspecified
Conditions
Interventions
Intervention 1: Patient divided to 3 equals groups. Group A(n=45) (control group) receive 30 micrograms per kilogeram per minute propofol plus10 sufentanli. Pain assessed every 5 minute by numerical
Prevention
Patient divided to 3 equals groups. Group A(n=45) (control group) receive 30 micrograms per kilogeram per minute propofol plus10 sufentanli. Pain assessed every 5 minute by numerical pain score(0= n
Patient divided to 3 equals groups. Group B(n=45) (intervention group) receive 30 micrograms per kilogeram per minute propofol plus 10 micrograms sufentanil and 15 micrograms of paraacetamol per minut
Patient divided to 3 equals groups. Group C(n=45) intervention group)receive 30 micrograms per kilogram per minute propofol plus 10 micrograms of sufentanil and music playing during ESWL. Pain assess
Sponsors
Bushehr University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The inclusion criteria are: the patients who candidate only for ESWL and American Society of Anesthesiologist( ASA )score I or II. The exclusion criteria are contraindication to use opioids; severe chronic respiratory disease and severe obesity.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain during ESWL. Timepoint: 45 minutes. Method of measurement: Numerical analogous pain scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurence of respiratory depression. Timepoint: 60 minutes. Method of measurement: Pulse oximetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Najafi Anaraki
Bushehr University of Medical Sciences
Outcome results
None listed